Josh Mandel-Brehm
Board Member
Camp4 Therapeutics Corp (CAMP)Board Member
ProMIS Neurosciences Inc. (PMN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Josh Mandel-Brehm
Josh Mandel-Brehm is recorded as Board Member and CEO at Camp4 Therapeutics Corp (CAMP) and Board Member at ProMIS Neurosciences Inc. (PMN). The proxy statement of Camp4 Therapeutics Corp reports total compensation of $3,327,238 for Josh Mandel-Brehm in fiscal 2025, including a base salary of $600,000. Disclosed compensation is on record for 3 fiscal years. Josh Mandel-Brehm has spoken on 1 investor event across 1 company, most recently for Camp4 Therapeutics Corp on March 9, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Camp4 Therapeutics Corp
Other people whose current roles at this company are on record from its filings.
- Doug Williams Chairman
- Kelly Gold CFO
- Amir Nashat Board Member
- Andrew J. Schwab Board Member
- Douglas Williams Board Member
- Douglas Williams, PhD Board Member
- Michael MacLean Board Member
- Murray Stewart Board Member
- Murray Stewart, DM FRCP Board Member
- Richard Young Board Member
Leadership on record at ProMIS Neurosciences Inc.
Other people whose current roles at this company are on record from its filings.
- Gail Farfel CEO
- Gail M. Farfel CEO
- Gail M. Farfel, PhD CEO
- Neil Warma CEO, Board Member
- Bill Wyman Board Member
- Eugene Williams Board Member
- Joshua Mandel-Brehm Board Member
- Maggie Shafmaster Board Member
- Maggie Shafmaster, Ph.D,J.D. Board Member
- Maggie Shafmaster, Ph.D., J.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Camp4 Therapeutics Corp (CAMP) | Chief Executive Officer | $600,000 | $3,327,238 |
| 2024 | Camp4 Therapeutics Corp (CAMP) | Chief Executive Officer | $557,250 | $2,294,985 |
| 2023 | Camp4 Therapeutics Corp (CAMP) | Chief Executive Officer | $546,000 | $696,281 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.